Spyre Therapeutics, Inc. - SYRE

Latest data: 9/14/2026 10:02:20 PM
EDGAR CIK 0001636282

Buy Breakdown

Total $0

Sell Breakdown

Total $17,946,596

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
09/01/2026
10b5-1
09/03/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $87.29
($1,309,410.00)
552,540 (-2.64%) Direct
08/03/2026
10b5-1
08/05/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $95.51
($1,432,705.05)
567,540 (-2.57%) Direct
07/01/2026
10b5-1
07/02/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $87.69
($1,315,346.42)
582,540 (-2.51%) Direct
06/22/2026
10b5-1
06/23/2026
Director
Sell
-20,000 @ $100.00
($2,000,000.00)
68,606 (-22.57%) Direct
06/01/2026
10b5-1
06/03/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $70.43
($1,056,486.02)
597,540 (-2.45%) Direct
05/08/2026
10b5-1
05/08/2026
Director
Sell
-80,000 @ $74.40
($5,952,050.43)
88,606 (-47.45%) Direct
05/01/2026
10b5-1
05/01/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $71.37
($1,070,507.00)
612,540 (-2.39%) Direct
04/01/2026
10b5-1
04/03/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $49.33
($739,912.32)
627,540 (-2.33%) Direct
03/02/2026
10b5-1
03/03/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $42.19
($632,866.00)
642,540 (-2.28%) Direct
02/02/2026
10b5-1
02/04/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $32.80
($492,045.15)
657,540 (-2.23%) Direct
01/02/2026
10b5-1
01/06/2026
Chief Executive Officer
CEO Director
Sell
-15,000 @ $30.68
($460,134.12)
671,907 (-2.18%) Direct
12/01/2025
10b5-1
12/03/2025
Chief Executive Officer
CEO Director
Sell
-15,000 @ $29.02
($435,355.50)
686,907 (-2.14%) Direct
11/03/2025
10b5-1
11/05/2025
Chief Executive Officer
CEO Director
Sell
-45,000 @ $23.33
($1,049,777.85)
701,907 (-6.02%) Direct